Dr. Sandra Kurtin, expert on
acute myeloid leukemia or
AML, explains that the
outlook and
treatment options for someone with AML are different depending on the
type of disease, any
genetic changes that are present, and other factors. Knowing your
AML subtype, including the results of
chromosome and genetic tests, is very important in knowing your outlook and planning for treatment.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.